Stimunity
Creation date : 05/2016
Stimunity develops biomedicines that restore the immune system's defenses and enable it to detect and then destroy cancer cells again, including metastases that are spread throughout the body. The technology underlying this biomedicine is based on non-infectious viral pseudo-particles which activate the STING pathway, a pathway for activating the innate immune system, resulting from research at the Institut Curie, the Inserm, and the University of Oxford.
Original laboratories: UMR932 Institut Curie / Inserm, Immunity and cancer
Establishments: Institut Curie / Inserm
Unit Director: Sebastian Amigorena
Laboratory Director: Nicolas Manel
